| 99.88 Data as of May 23 |  -0.69 / -0.69%Today’s Change | 81.82 Today|||52-Week Range 119.54 | +6.55% Year-to-Date |
| Positive Data on Bayer Candidate - Analyst Blog May 23 / Zacks.com | 5 Stocks Underperforming Today In The Drugs Industry May 20 / TheStreet.com |
| Alkermes Reports Earnings for Q4 - Analyst Blog May 23 / Zacks.com | Biogen's Hemophilia BLA Accepted - Analyst Blog May 20 / Zacks.com |
| Notable Two Hundred Day Moving Average Cross - ALXN May 23 / TheStreet.com | Bayer's Xofigo Cleared in the US - Analyst Blog May 16 / Zacks.com |
| Bayer Files Riociguat in Japan - Analyst Blog May 21 / Zacks.com | Shire - rarity value May 03 / FT.com |
| Yet Another Acquisition for Bayer - Analyst Blog May 21 / Zacks.com |
| Previous close | 100.57 |
| Today’s open | 99.74 |
| Day’s range | -- - -- |
| Volume | 779,971 |
| Average volume (3 months) | 1,605,906 |
| Market cap | $19.5B |
| Dividend yield | -- |
| Earnings growth (last year) | +40.66% |
| Earnings growth (this year) | +38.62% |
| Earnings growth (next 5 years) | +23.60% |
| Revenue growth (last year) | +41.93% |
| P/E ratio | 68.9 |
| Price/Sales | 15.92 |
| Price/Book | 9.87 |
| Today’s change | Today’s % change | |
|---|---|---|
| SHPGShire PLC | -0.30 | -0.31% |
| VRTXVertex Pharmaceutica... | +0.05 | +0.06% |
| ACTActavis Inc | -1.96 | -1.51% |
| ZTSZoetis Inc | -0.71 | -2.12% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $0.68 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | $254.8M |
| Net profit margin | 22.73% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer, Treasurer & Director Leonard Bell, MD |
Chief Global Operations Officer & Executive VP Stephen P. Squinto, PhD |
Corporate headquarters Cheshire, Connecticut |
.
